Agreement further expands Angelini Pharma’s strong portfolio and deep therapeutic expertise in brain health, following a series of strategic partnerships in the space, including in orphan and rare ...
Chef Gino Angelini delivers one of the city’s best Italian dining experiences ...
Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience Under the terms of the multi-year agreement, Quiver ...
Bringing a sun-drenched summer from Italy to Los Angeles, the Peninsula Beverly Hills and Angelini Osteria present Angelini Grill: a culinary residency open from July 8-Aug. 2. The restaurant, ...
Rome-based Angelini Pharma has inked a multiyear deal with Massachusetts biotech Quiver Bioscience to advance novel therapies for genetic epilepsies, which could garner up to $120 million in milestone ...
The longtime power lunch favorite on Beverly Boulevard embraces a new community by the sea with fans including Chris Pine. By Evan Nicole Brown Culture Writer Angelini Osteria, a longtime Hollywood ...
ROME, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results